Truace
Subscribe

Patients, caregivers and providers in New York discuss a hypothetical AI companion for schizophrenia

Study title: Stakeholder perspectives on artificial intelligence in schizophrenia care

Researchers conducted exploratory focus groups at a large academic health center in New York City with 17 patients with schizophrenia spectrum disorders, 7 caregivers, and 4 providers to discuss a hypothetical AI companion tool. Thematic analysis identified five themes about accessibility, uncertainty about role, trust, supplementing human care, and limiting use to low-risk support.

Read the study abstract

Background Artificial intelligence (AI) is explored as a tool to expand access to mental health care, offering support and self-disclosure. To date, the perspectives of individuals with schizophrenia on AI have been absent from the medical literature. This exploratory study represents an effort to report schizophrenia patient perspectives on AI chatbots through a focus group. Methods We conducted an exploratory, cross-sectional, qualitative study using semi-structured focus groups at a large academic health cent…

By the Truvace desk1 min read1 sourceEvidence: Emerging · 37/100 — Interviews or qualitative study · n = 28 · 1 independent sourcePeer-reviewedTRV-2026-1046· cite & verify
Stakeholder perspectives on artificial intelligence in schizophrenia care
Md Mahfuz Alam Advisor Ministry of Information and Broadcasting Speech Focus Group Discussion Directorate of Mass Communication Bangladesh Secretariat 2025-04-22 (PID-0002271) by Press Information Department. Public domain
Trace impact readingContested
P 48The P score combines the specificity and measured human impact of the grounded problem claim with the strength of this Trace’s cited sources.

Both sides are scored from claims and sources, not community votes.

G 50The G score combines the specificity and measured human impact of the grounded gain claim with the strength of this Trace’s cited sources.

In brief

The findings matter because perspectives of people with schizophrenia have been absent from medical literature on AI mental health tools, yet this group faces specific privacy and trust vulnerabilities. Uncertainty remains about whether perceived acceptability would translate into safe, effective use outside this small exploratory sample and single-site context.

Main points

  1. Focus groups included 17 patients with schizophrenia spectrum disorders, 7 caregivers, and 4 providers.
  2. Discussions explored familiarity with AI, privacy, and perceived utility of a hypothetical AI companion tool.
  3. Theme 'A Tool, Not a Therapist' emphasized AI was acceptable only as a supplement to, not a replacement for, human care.
  4. Theme 'Keep It Low-Risk' limited acceptable uses to supportive functions.

The gain

Participants with schizophrenia recognized an AI companion as a potentially accessible source of support between clinical visits.

The problem

Participants identified trust as the central barrier to using an AI companion, driven by privacy concerns and vulnerabilities specific to schizophrenia.

The rundown

The study used semi-structured focus groups and thematic analysis of transcripts to elicit views on familiarity with AI, privacy, and utility. Five themes emerged, including uncertainty captured as 'What Would It Do?' and a preference for low-risk supportive functions.

Authors conclude implementation should emphasize transparency, trust, and clear boundaries, with AI designed to support, not replace, existing care, reflecting the 'A Tool, Not a Therapist' theme.

What this doesn’t fix

Findings are exploratory and based on a small, single-site qualitative sample, limiting generalizability beyond this New York City academic center.

Sources

  1. Peer-reviewedPsychological Medicine2026-09-09

The debate